Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis

Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis

10.1016/S2214-109X(18)30422-4

Saved in:

Bibliographic Details
Main Authors:	Chen, C., Cervero Liceras, F., Flasche, S., Sidharta, S., Yoong, J., Sundaram, N., Jit, M.
Other Authors:	SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
Published:	Elsevier Ltd 2022
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/213997
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

An updated cost-effectiveness analysis of pneumococcal conjugate vaccine among children in Thailand
by: Piyameth Dilokthornsakul, et al.
Published: (2019)

An updated cost-effectiveness analysis of pneumococcal conjugate vaccine among children in Thailand
by: Piyameth Dilokthornsakul, et al.
Published: (2020)

A cost-effectiveness analysis of the 13-valent pneumococcal conjugated vaccine and the 23-valent pneumococcal polysaccharide vaccine among Thai older adult
by: Ngamprasertchai T.
Published: (2023)

The global impact and cost-effectiveness of a melioidosis vaccine
by: Nantasit Luangasanatip, et al.
Published: (2020)

Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster
by: Russell, F.M., et al.
Published: (2014)

Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context?
by: Wantanee Kulpeng, et al.
Published: (2018)

Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: protection at what price in the Thai context?
by: Wantanee Kulpenga, et al.
Published: (2014)

Pneumococcal Vaccination in Children: A Systematic Review and Meta-Analysis of Cost-Effectiveness Studies
by: Syeed M.S.
Published: (2023)

Pneumococcal infection among children before introduction of 13-valent pneumococcal conjugate vaccine, Cambodia
by: Paul Turner, et al.
Published: (2018)

Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media
by: Bogaert, D, et al.
Published: (2020)

Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: A questionnaire-based assessment
by: How, C.H, et al.
Published: (2020)

Adult invasive pneumococcal disease pre- and peri-pneumococcal conjugate vaccine introduction in a tertiary hospital in Singapore
by: Hsu, L.-Y., et al.
Published: (2015)

Pneumococcal colonization and severity of pneumonia in hospitalized Cambodian children following introduction of the 13-valent pneumococcal conjugate vaccine
by: Miliya T.
Published: (2023)

Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites
by: Feikin D.R., et al.
Published: (2019)

Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites
by: Daniel R. Feikin, et al.
Published: (2018)

Pneumococcal vaccine
by: V. Thamlikitkul
Published: (2018)

Kawasaki Disease following administration of 13-valent pneumococcal conjugate vaccine in young children
by: Yung, C.F., et al.
Published: (2021)

Do pneumococcal conjugate vaccines represent good value for money in a lower-middle income country? A cost-utility analysis in the Philippines
by: Haasis M.A., et al.
Published: (2020)

Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine
by: Russell, F.M., et al.
Published: (2014)

Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy
by: Russell, F.M., et al.
Published: (2014)

Kawasaki disease following administration of 13-valent pneumococcal conjugate vaccine in young children
by: Yung, Chee Fu, et al.
Published: (2020)

Impact of 13-Valent Pneumococcal Conjugate Vaccine on Colonization and Invasive Disease in Cambodian Children
by: Paul Turner, et al.
Published: (2020)

The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children
by: Chareeya Thanee, et al.
Published: (2018)

Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age
by: Russell, F.M., et al.
Published: (2014)

A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV
by: Wilck M.
Published: (2023)

Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV
by: Lerato Mohapi, et al.
Published: (2022)

Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV
by: Mohapi L.
Published: (2023)

Corrigendum to " The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children" [Vaccine 29 (2011) 5886-5891]
by: Chareeya Thanee, et al.
Published: (2018)

Predictors for bacteremia in febrile sickle cell disease children in the post-7-valent pneumococcal conjugate vaccine era
by: Todd P. Chang, et al.
Published: (2018)

Nasopharyngeal carriage of streptococcus pneumoniae in gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings
by: Cheung, Y.-B., et al.
Published: (2014)

Continued control of pneumococcal disease in the UK - The impact of vaccination
by: Gladstone, R.A, et al.
Published: (2020)

Efficacy of Pneumococcal Vaccine on Otitis Media: A Systematic Review and Meta-Analysis
by: Wannarong T.
Published: (2023)

The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004
by: Mooney, J.D, et al.
Published: (2020)

A dynamic model of pneumococcal infection in the United States: Implications for prevention through vaccination
by: Thierry Van Effelterre, et al.
Published: (2018)

Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore
by: Phua, LC, et al.
Published: (2021)

Pneumococcal carriage among high-risk adults in a country with nonmandatory pneumococcal vaccination during the coronavirus disease 2019 pandemic
by: Ngamprasertchai T.
Published: (2023)

Cost-Effectiveness Analysis for Influenza Vaccination Coverage and Timing in Tropical and Subtropical Climate Settings: A Modeling Study
by: Yue, Mu, et al.
Published: (2023)

Serotype coverage of pneumococcal conjugate vaccine and drug susceptibility of Streptococcus pneumoniae isolated from invasive or non-invasive diseases in central Thailand, 2006-2009
by: Somporn Srifeungfung, et al.
Published: (2018)

Acute Respiratory Infections and Child Survival: Potential Role of Pneumococcal vaccine control
by: Perpustakaan UGM, i-lib
Published: (1989)

Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape
by: Nicholas J. Croucher, et al.
Published: (2018)